![Indranil Dey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Indranil Dey
Algemeen Directeur bij
BLUEJAY DIAGNOSTICS, INC.
Vermogen: 35 365 $ op 31-08-2026
Profiel
Indranil Dey is the founder of Bluejay Diagnostics, Inc., founded in 2015, holding the titles of President, CEO, CFO, CAO & Director.
Dr. Dey was the founder of Lana Management & Business Research International LLC, founded in 2007, and served as Chief Operating Officer from 2008 to 2015.
Dr. Dey is currently a Director at Laminar Pharma, Inc. Former jobs include Manager-Technology Licensing at Ciba-Geigy Corp., Head-Western US Business Development at IMPATH, Inc. from 2001 to 2005, Manager-Technology Licensing at Thomas Jefferson University, Vice President-Business Development & Market at AstraZeneca Computational Pathology GmbH from 2005 to 2007, and Chief Business Officer at Genmethrax, Inc. Education includes an MBA from the University of Cambridge, a doctorate from the Hungarian Academy of Sciences, and undergraduate and graduate degrees from Visva-Bharati University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-08-2026 | 40.649 ( 0,91% ) | 35 365 $ | 31-08-2026 |
Actieve functies van Indranil Dey
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Algemeen Directeur | 01-01-2015 |
Laminar Pharma, Inc.
 Laminar Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 2006, Laminar Pharma, Inc. specializes in the discovery, design, and clinical development of drugs using membrane lipid therapy, targeting cell membrane lipids to modulate signaling pathways. The private company is based in Acton, MA. The company develops synthetic fatty acid derivatives for serious diseases such as aggressive cancers, neurodegenerative disorders, metabolic, inflammatory, and rare orphan diseases. Key products include an oral anticancer drug for glioblastoma in advanced clinical trials, as well as candidates for Alzheimer’s disease and neuroprotection. Laminar Pharma collaborates with academic and research institutions, leads a European consortium, and seeks partnerships and investment to advance its therapies. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Indranil Dey
| Bedrijven | Functie | Einde |
|---|---|---|
Lana Management & Business Research International LLC
 Lana Management & Business Research International LLC Miscellaneous Commercial ServicesCommercial Services Lana Management & Business Research International LLC (LMBRI) is a business consultancy specializing in strategic support across industries such as healthcare, diagnostics, pharmaceuticals, government, defense, and security. The private company is based in Acton, MA. The firm provides expertise in market entry strategies, strategic planning, program and project management, and customer relationship enhancement. LMBRI assists clients in navigating regulatory environments, market dynamics, and supply chain challenges by delivering evidence-based recommendations for business growth, sustainability, and revenue generation. The company's services include project viability and risk assessments—financial, legal, and technical—to guide decision-making and manage non-financial risks in volatile markets. The senior advisory team offers tailored strategic roadmaps and ongoing program management throughout project lifecycles, including product launches and market development. LMBRI also provides regulatory consulting to diagnostic and pharmaceutical companies, supporting compliance with authorities such as the FDA and ISO. The company was founded by Indranil Dey, Svetlana Dey. Svetlana Dey has been the CEO of the company since 2008. | Oprichter | 01-01-2015 |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Develops and markets biomedical imaging and data analysis software solutions | Corporate Officer/Principal | 01-01-2007 |
IMPATH, Inc.
 IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Corporate Officer/Principal | 01-01-2005 |
Genmethrax, Inc. | Corporate Officer/Principal | - |
Ciba-Geigy Corp.
 Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Corporate Officer/Principal | - |
Opleiding van Indranil Dey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Ciba-Geigy Corp.
Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Health Technology |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Health Services |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Develops and markets biomedical imaging and data analysis software solutions | Technology Services |
Hungarian Academy of Sciences
 Hungarian Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Visva-Bharati University
 Visva-Bharati University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bluejay Diagnostics, Inc.
 Bluejay Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets non-invasive, point-of-care tests and devices | Health Technology |
Lana Management & Business Research International LLC
Lana Management & Business Research International LLC Miscellaneous Commercial ServicesCommercial Services Lana Management & Business Research International LLC (LMBRI) is a business consultancy specializing in strategic support across industries such as healthcare, diagnostics, pharmaceuticals, government, defense, and security. The private company is based in Acton, MA. The firm provides expertise in market entry strategies, strategic planning, program and project management, and customer relationship enhancement. LMBRI assists clients in navigating regulatory environments, market dynamics, and supply chain challenges by delivering evidence-based recommendations for business growth, sustainability, and revenue generation. The company's services include project viability and risk assessments—financial, legal, and technical—to guide decision-making and manage non-financial risks in volatile markets. The senior advisory team offers tailored strategic roadmaps and ongoing program management throughout project lifecycles, including product launches and market development. LMBRI also provides regulatory consulting to diagnostic and pharmaceutical companies, supporting compliance with authorities such as the FDA and ISO. The company was founded by Indranil Dey, Svetlana Dey. Svetlana Dey has been the CEO of the company since 2008. | Commercial Services |
Laminar Pharma, Inc.
Laminar Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 2006, Laminar Pharma, Inc. specializes in the discovery, design, and clinical development of drugs using membrane lipid therapy, targeting cell membrane lipids to modulate signaling pathways. The private company is based in Acton, MA. The company develops synthetic fatty acid derivatives for serious diseases such as aggressive cancers, neurodegenerative disorders, metabolic, inflammatory, and rare orphan diseases. Key products include an oral anticancer drug for glioblastoma in advanced clinical trials, as well as candidates for Alzheimer’s disease and neuroprotection. Laminar Pharma collaborates with academic and research institutions, leads a European consortium, and seeks partnerships and investment to advance its therapies. | Commercial Services |
Genmethrax, Inc. |
